| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
|
Vankadari, Naveen
|
|
|
56 |
2 |
p.
|
artikel
|
| 2 |
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
|
Tripathy, Satyajit
|
|
|
56 |
2 |
p.
|
artikel
|
| 3 |
Cardiac effects and toxicity of chloroquine: a short update
|
Mubagwa, Kanigula
|
|
|
56 |
2 |
p.
|
artikel
|
| 4 |
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital
|
Protonotariou, Efthymia
|
|
|
56 |
2 |
p.
|
artikel
|
| 5 |
Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications
|
Karakonstantis, Stamatis
|
|
|
56 |
2 |
p.
|
artikel
|
| 6 |
Combating devastating COVID-19 by drug repurposing
|
Pawar, Ashish Yashwantrao
|
|
|
56 |
2 |
p.
|
artikel
|
| 7 |
Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
|
Yu, Ran
|
|
|
56 |
2 |
p.
|
artikel
|
| 8 |
Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study
|
Bani-Sadr, Firouzé
|
|
|
56 |
2 |
p.
|
artikel
|
| 9 |
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
|
Song, Yang
|
|
|
56 |
2 |
p.
|
artikel
|
| 10 |
Discontinuation of Antibiotics in Patients with Neurological Conditions – A Study on the Impact of an Antimicrobial Stewardship Program (ASP) in a Tertiary Institution
|
Loo, Li Wen
|
|
|
56 |
2 |
p.
|
artikel
|
| 11 |
Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials
|
Green, R. Madison
|
|
|
56 |
2 |
p.
|
artikel
|
| 12 |
Extra-respiratory manifestations of COVID-19
|
Lai, Chih-Cheng
|
|
|
56 |
2 |
p.
|
artikel
|
| 13 |
Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b
|
Hong, Sun In
|
|
|
56 |
2 |
p.
|
artikel
|
| 14 |
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods
|
Laurent, Sacha
|
|
|
56 |
2 |
p.
|
artikel
|
| 15 |
Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia
|
Mokrousov, Igor
|
|
|
56 |
2 |
p.
|
artikel
|
| 16 |
High-risk KPC-producing Klebsiella pneumoniae lack type I R-M systems
|
Zhou, Ying
|
|
|
56 |
2 |
p.
|
artikel
|
| 17 |
How preclinical infection models help define antibiotic doses in the clinic
|
Tängdén, Thomas
|
|
|
56 |
2 |
p.
|
artikel
|
| 18 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
56 |
2 |
p.
|
artikel
|
| 19 |
In vitro co-infection by cytomegalovirus improves the antiviral activity of ganciclovir against human adenovirus
|
Aguilar-Guisado, Manuela
|
|
|
56 |
2 |
p.
|
artikel
|
| 20 |
Is teicoplanin a complementary treatment option for COVID-19? The question remains
|
Ceccarelli, Giancarlo
|
|
|
56 |
2 |
p.
|
artikel
|
| 21 |
Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis
|
Perez-Garcia, Luis A.
|
|
|
56 |
2 |
p.
|
artikel
|
| 22 |
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
|
Pani, Arianna
|
|
|
56 |
2 |
p.
|
artikel
|
| 23 |
Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa
|
Iannaccone, Marco
|
|
|
56 |
2 |
p.
|
artikel
|
| 24 |
Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris
|
Barreto, Thayná Lopes
|
|
|
56 |
2 |
p.
|
artikel
|
| 25 |
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line
|
Ciccullo, Arturo
|
|
|
56 |
2 |
p.
|
artikel
|
| 26 |
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
|
He, Jun
|
|
|
56 |
2 |
p.
|
artikel
|
| 27 |
Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure
|
André-Garnier, Elisabeth
|
|
|
56 |
2 |
p.
|
artikel
|
| 28 |
Procalcitonin levels in COVID-19 patients
|
Hu, Rui
|
|
|
56 |
2 |
p.
|
artikel
|
| 29 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies
|
Sharma, Atul
|
|
|
56 |
2 |
p.
|
artikel
|
| 30 |
Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
|
Gaspari, Valeria
|
|
|
56 |
2 |
p.
|
artikel
|
| 31 |
Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19
|
Shi, Hua
|
|
|
56 |
2 |
p.
|
artikel
|
| 32 |
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
|
Fantini, Jacques
|
|
|
56 |
2 |
p.
|
artikel
|
| 33 |
The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms
|
Li, Yiman
|
|
|
56 |
2 |
p.
|
artikel
|
| 34 |
Title Page & Editorial Board
|
|
|
|
56 |
2 |
p.
|
artikel
|
| 35 |
Tocilizumab administration in a refractory case of COVID-19
|
Dastan, Farzaneh
|
|
|
56 |
2 |
p.
|
artikel
|
| 36 |
Tracking the evolution of the two successful CC59 methicillin-resistant Staphylococcus aureus clones in Taiwan: the divergence time of the two clades is estimated to be the 1980s
|
Su, Yong-Chao
|
|
|
56 |
2 |
p.
|
artikel
|
| 37 |
Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol
|
Abdul Rahim, Nusaibah
|
|
|
56 |
2 |
p.
|
artikel
|
| 38 |
Widely available lysosome targeting agents should be considered as potential therapy for COVID-19
|
Homolak, J.
|
|
|
56 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving